The Human UDP-glucuronosyltransferase UGT2A1 and UGT2A2 Enzymes Are Highly Active in Bile Acid Glucuronidation

Overview

Journal Drug Metab Dispos

Specialty Pharmacology

Date 2013 Jun 13

PMID 23756265

Citations 20

Authors

Martin Perreault

Louis Gauthier-Landry

Jocelyn Trottier

Melanie Verreault

Patrick Caron

Moshe Finel

Olivier Barbier

Affiliations

Soon will be listed here.

Abstract

Bile acids (BA) are essential modulators of lipid, glucose, and cholesterol homeostasis, but they exert cytotoxic effects in the cholestatic liver. Glucuronidation, catalyzed by the UDP-glucuronosyltransferase (UGT) enzymes is a pharmacologically relevant BA detoxification process. The present study characterized the BA-conjugating activity of the little-studied human UGTs of subfamily 2A: UGT2A1, 2A2, and 2A3. Recombinant UGT2As, expressed in baculovirus-infected insect cells, were assayed for the glucuronidation of six major bile acids: chenodeoxycholic acid (CDCA), cholic acid (CA), lithocholic acid (LCA), deoxycholic acid (DCA), hyocholic acid (HCA) and hyodeoxycholic acid (HDCA). UGT2A3 exhibited detectable but very low activity with all the tested BA substrates. UGT2A1 was highly efficient in forming LCA-3 and LCA-24G, CDCA-24, DCA-24, HCA-24, and HDCA-24G, whereas UGT2A2 was the most active enzyme for CA-24G and CDCA-24G formation and also was able to generate HDCA-6G, HDCA-24G, LCA-24G, and HCA-24G. The Km values of UGT2A1 varied between 102.2 ± 14.3 µM and 2.4 ± 1.2 mM. With the exception of CA-24G, a low affinity substrate for UGT2A2, all the Km values for UGT2A2 were in the 100 to 400 µM range. We demonstrate the high reactivity of the human UGT2A1 and UGT2A2 for bile acid glucuronidation. The physiologic importance of these reactions to BA disposition remains, however, to be clarified in vivo.

Citing Articles

Nrf-2/HO-1 activation protects against oxidative stress and inflammation induced by metal welding fume UFPs in 16HBE cells.

Ying M, Yang Y, Huo Q, Sun J, Hong X, Yang F Sci Rep. 2024; 14(1):24057.

PMID: 39402078 PMC: 11473639. DOI: 10.1038/s41598-024-74599-8.

PPAR-Mediated Bile Acid Glucuronidation: Therapeutic Targets for the Treatment of Cholestatic Liver Diseases.

Gallucci G, Hayes C, Boyer J, Barbier O, Assis D, Ghonem N Cells. 2024; 13(15.

PMID: 39120326 PMC: 11312002. DOI: 10.3390/cells13151296.

Transcriptomic Association Analysis of the Metabolic Mechanism of Sulfamethoxazole in Channel Catfish ().

Du X, Sun R, Zhang L, Liu Y, Ai X Animals (Basel). 2024; 14(7).

PMID: 38612297 PMC: 11011017. DOI: 10.3390/ani14071059.

Acute and subacute hepatotoxicity of genipin in mice and its potential mechanism.

Wang S, Ge S, Chen Y, Zhou F, Wang J, Chen L Heliyon. 2023; 9(11):e21834.

PMID: 38027867 PMC: 10663932. DOI: 10.1016/j.heliyon.2023.e21834.

The Uridine diphosphate (UDP)-glycosyltransferases (UGTs) superfamily: the role in tumor cell metabolism.

Liu W, Li J, Zhao R, Lu Y, Huang P Front Oncol. 2023; 12:1088458.

PMID: 36741721 PMC: 9892627. DOI: 10.3389/fonc.2022.1088458.

References

Pauli-Magnus C, Stieger B, Meier Y, Kullak-Ublick G, Meier P . Enterohepatic transport of bile salts and genetics of cholestasis. J Hepatol. 2005; 43(2):342-57. DOI: 10.1016/j.jhep.2005.03.017. View

Mackenzie P, Bock K, Burchell B, Guillemette C, Ikushiro S, Iyanagi T . Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily. Pharmacogenet Genomics. 2005; 15(10):677-85. DOI: 10.1097/01.fpc.0000173483.13689.56. View

Sneitz N, Vahermo M, Mosorin J, Laakkonen L, Poirier D, Finel M . Regiospecificity and stereospecificity of human UDP-glucuronosyltransferases in the glucuronidation of estriol, 16-epiestriol, 17-epiestriol, and 13-epiestradiol. Drug Metab Dispos. 2013; 41(3):582-91. DOI: 10.1124/dmd.112.049072. View

Zhang H, Patana A, Mackenzie P, Ikushiro S, Goldman A, Finel M . Human UDP-glucuronosyltransferase expression in insect cells: ratio of active to inactive recombinant proteins and the effects of a C-terminal his-tag on glucuronidation kinetics. Drug Metab Dispos. 2012; 40(10):1935-44. DOI: 10.1124/dmd.112.046086. View

Court M, Hazarika S, Krishnaswamy S, Finel M, Williams J . Novel polymorphic human UDP-glucuronosyltransferase 2A3: cloning, functional characterization of enzyme variants, comparative tissue expression, and gene induction. Mol Pharmacol. 2008; 74(3):744-54. PMC: 2574548. DOI: 10.1124/mol.108.045500. View

Verreault M, Kaeding J, Caron P, Trottier J, Grosse L, Houssin E . Regulation of endobiotics glucuronidation by ligand-activated transcription factors: physiological function and therapeutic potential. Drug Metab Rev. 2009; 42(1):110-22. DOI: 10.3109/03602530903219220. View

Itaaho K, Mackenzie P, Ikushiro S, Miners J, Finel M . The configuration of the 17-hydroxy group variably influences the glucuronidation of beta-estradiol and epiestradiol by human UDP-glucuronosyltransferases. Drug Metab Dispos. 2008; 36(11):2307-15. DOI: 10.1124/dmd.108.022731. View

Pillot T, Ouzzine M, Fournel-Gigleux S, Lafaurie C, Radominska A, Burchell B . Glucuronidation of hyodeoxycholic acid in human liver. Evidence for a selective role of UDP-glucuronosyltransferase 2B4. J Biol Chem. 1993; 268(34):25636-42. View

Bushey R, Dluzen D, Lazarus P . Importance of UDP-glucuronosyltransferases 2A2 and 2A3 in tobacco carcinogen metabolism. Drug Metab Dispos. 2012; 41(1):170-9. PMC: 3533432. DOI: 10.1124/dmd.112.049171. View

10.

Trottier J, Caron P, Straka R, Barbier O . Profile of serum bile acids in noncholestatic volunteers: gender-related differences in response to fenofibrate. Clin Pharmacol Ther. 2011; 90(2):279-86. PMC: 4666518. DOI: 10.1038/clpt.2011.124. View

11.

Manevski N, Troberg J, Svaluto-Moreolo P, Dziedzic K, Yli-Kauhaluoma J, Finel M . Albumin stimulates the activity of the human UDP-glucuronosyltransferases 1A7, 1A8, 1A10, 2A1 and 2B15, but the effects are enzyme and substrate dependent. PLoS One. 2013; 8(1):e54767. PMC: 3553014. DOI: 10.1371/journal.pone.0054767. View

12.

Sneitz N, Krishnan K, Covey D, Finel M . Glucuronidation of the steroid enantiomers ent-17β-estradiol, ent-androsterone and ent-etiocholanolone by the human UDP-glucuronosyltransferases. J Steroid Biochem Mol Biol. 2011; 127(3-5):282-8. PMC: 3234363. DOI: 10.1016/j.jsbmb.2011.08.008. View

13.

Miners J, Mackenzie P, Knights K . The prediction of drug-glucuronidation parameters in humans: UDP-glucuronosyltransferase enzyme-selective substrate and inhibitor probes for reaction phenotyping and in vitro-in vivo extrapolation of drug clearance and drug-drug interaction potential. Drug Metab Rev. 2009; 42(1):196-208. DOI: 10.3109/03602530903210716. View

14.

Lazard D, Zupko K, Poria Y, Nef P, Lazarovits J, Horn S . Odorant signal termination by olfactory UDP glucuronosyl transferase. Nature. 1991; 349(6312):790-3. DOI: 10.1038/349790a0. View

15.

Gall W, Zawada G, Mojarrabi B, Tephly T, Green M, Coffman B . Differential glucuronidation of bile acids, androgens and estrogens by human UGT1A3 and 2B7. J Steroid Biochem Mol Biol. 1999; 70(1-3):101-8. DOI: 10.1016/s0960-0760(99)00088-6. View

16.

Bushey R, Chen G, Blevins-Primeau A, Krzeminski J, Amin S, Lazarus P . Characterization of UDP-glucuronosyltransferase 2A1 (UGT2A1) variants and their potential role in tobacco carcinogenesis. Pharmacogenet Genomics. 2010; 21(2):55-65. PMC: 3019304. DOI: 10.1097/FPC.0b013e328341db05. View

17.

Jedlitschky G, Cassidy A, Sales M, Pratt N, Burchell B . Cloning and characterization of a novel human olfactory UDP-glucuronosyltransferase. Biochem J. 1999; 340 ( Pt 3):837-43. PMC: 1220318. View

18.

Sneitz N, Court M, Zhang X, Laajanen K, Yee K, Dalton P . Human UDP-glucuronosyltransferase UGT2A2: cDNA construction, expression, and functional characterization in comparison with UGT2A1 and UGT2A3. Pharmacogenet Genomics. 2009; 19(12):923-34. PMC: 2928392. DOI: 10.1097/FPC.0b013e3283330767. View

19.

Sten T, Bichlmaier I, Kuuranne T, Leinonen A, Yli-Kauhaluoma J, Finel M . UDP-glucuronosyltransferases (UGTs) 2B7 and UGT2B17 display converse specificity in testosterone and epitestosterone glucuronidation, whereas UGT2A1 conjugates both androgens similarly. Drug Metab Dispos. 2008; 37(2):417-23. DOI: 10.1124/dmd.108.024844. View

20.

Trottier J, Verreault M, Grepper S, Monte D, Belanger J, Kaeding J . Human UDP-glucuronosyltransferase (UGT)1A3 enzyme conjugates chenodeoxycholic acid in the liver. Hepatology. 2006; 44(5):1158-70. DOI: 10.1002/hep.21362. View